Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.

  • STATUS
    Recruiting
Updated on 8 November 2020

Summary

Living with Multiple Sclerosis? Enrolling for a 96-week, non-placebo, comparative trial.

Description

Are you living with Multiple Sclerosis? Have you experienced a worsening of your MS symptoms or the onset of new symptoms in the last two years? If so, you may qualify for a research study.

NeuroTrials Research is conducting a 96 week, non-placebo, comparative trial to determine whether an investigational drug is more effective than a currently approved drug in patients with relapsing multiple sclerosis.

If you are between the ages of 18 and 55, have been diagnosed with multiple sclerosis and do not have a diagnosis of primary progressive MS or any other neurological disorders, you may qualify.

Qualified participants receive study related exams and study drug at no cost, and compensation for time and travel is available.

You can help keep MS research moving forward. Without volunteer participation, MS research stands still. Get moving - call 404-851-9934 or go to www.neurotrials.com

Patient Inclusion Criteria:

  • Are 18-55
  • Have been diagnosed with MS
  • Have experienced either a worsening of MS symptoms or new symptoms

Patient Exclusion Criteria:

  • Do not have a diagnosis of primary progressive MS
  • Have no other neurological disorders

Details
Condition Multiple Sclerosis
Clinical Study IdentifierTX135493
Last Modified on8 November 2020

Eligibility

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note